Login

Oyster Point Pharma, Inc. SEC Filings

Filed On Filing
14 Feb 2023 SC 13G/A
14 Feb 2023 SCHEDULE 13G/A, AMENDMENT #2
14 Feb 2023 OYSTER POINT PHARMA, INC.
13 Jan 2023 15-12G
13 Jan 2023 SC 13D/A
13 Jan 2023 8-K/A: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more

On January 3, 2023 and in connection with the consummation of the Offer (as defined below) and the Merger (as defined below), Oyster Point prepaid in full all of its outstanding obligations in respect of principal, interest, expenses, fe...

09 Jan 2023 NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#2E)
05 Jan 2023 EFFECT
05 Jan 2023 SC 13D/A
05 Jan 2023 Form 4: InvOpps Gp IV, L.l.c., Director and 3 others

Disposed of 2,768,586 shares (Tender Offer)

04 Jan 2023 Form 4: Versant Venture Capital VI, L.p., 10% owner and 8 others

Disposed of 3,657,618 shares (Tender Offer)

04 Jan 2023 Form 4: Behbahani Ali, Director

Returned 13,639 shares to the issuer · Disposed of 10,558 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: New Enterprise Associates 14, L.p., 10% owner and 6 others

Disposed of 5,925,287 shares (Tender Offer)

04 Jan 2023 Form 4: Weisner Aimee S, Director

Returned 36,764 shares to the issuer · Disposed of 10,558 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: Tsai Benjamin, Director

Disposed of 10,066 shares (Tender Offer) · Returned 3,573 shares to the issuer · Disposed of 10,558 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: Santel Donald J, Director

Disposed of 5,489 shares (Tender Offer) · Returned 8,198 shares to the issuer · Disposed of 20,529 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: Ozawa Clare, Director

Returned 14,637 shares to the issuer · Disposed of 3,657,618 shares (Tender Offer) · Disposed of 10,558 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: Nau Jeffrey, Director

Gave up 2,607 shares to cover exercise price or tax ($30.5K) · Disposed of 100,738 shares (Tender Offer) · Returned 48,975 shares to the issuer · 2 more

04 Jan 2023 Form 4: Murray Mark Anthony, Director

Returned 122,086 shares to the issuer · Disposed of 190,834 Stock Option (Right to Buy) (Disposition to Issuer)

04 Jan 2023 Form 4: Lochner Daniel, Chief Financial Officer

Gave up 938 shares to cover exercise price or tax ($11K) · Disposed of 56,289 shares (Tender Offer) · Returned 20,236 shares to the issuer · 2 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support